Top Brand
Salt CompositionMetformin 500mg + Voglibose 0.3mg
Our Recommendation
Zarbose M 500/0.3mg Tablet 10s
4,244+ trust this
WHO GMP Certified
4,244+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Type 2 diabetes mellitus
Customers also bought
More About Zarbose-M
Benefits
In Treatment of Type 2 diabetes mellitus Zarbose M 500mg/0.3mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. Zarbose M 500mg/0.3mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Zarbose M 500mg/0.3mg Tablet is to be taken with food.
How it works
Zarbose M 500mg/0.3mg Tablet is a combination of two antidiabetic medicines: Metformin and voglibose. Metformin lowers the production and absorption of sugar in your body and allows better use of existing insulin. Voglibose inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.
Unsafe: Avoid consuming alcohol with Zarbose M 500mg/0.3mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Zarbose M 500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Zarbose M 500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
SAFE - Zarbose M 500mg/0.3mg Tablet does not usually affect your ability to drive. However, patients should be alerted to the risk of hypoglycemia when it is used in combination with other antidiabetic agents such as sulfonylureas, insulin, and repaglinide.
Caution Advised: Zarbose M 500mg/0.3mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Zarbose M 500mg/0.3mg Tablet may be needed. Doctor consultation is advised. Use of Zarbose M 500mg/0.3mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Seek medical advice from your doctor: There is limited information available on the use of Zarbose M 500mg/0.3mg Tablet in patients with liver disease. Doctor consultation is advised.
What if I forget to take it?
If a dose of Zarbose M 500mg/0.3mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
BIOCHEM PHARMA, LG 113 / A, Xth Central Mall, Mahavir Nagar, 90ft Road, Next to D Mart, Kandivali - West, Mumbai - 400067.
References
CiplaMed. Voglibose + Metformin hydrochloride (08 Apr. 2019)
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (08 Apr. 2019)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Metformin hydrochloride and Voglibose (Tablets) (21 Oct. 2021)
Voglibose and Metformin Hydrochloride Tablets (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
